The Enterprise Value as of September 2024 (TTM) for Pasithea Therapeutics Corp. (KTTA) is -3926976.00

According to Pasithea Therapeutics Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is -3926976.00. This represents a change of -30.48% compared to the average of -5648304.96 of the last 4 quarters.

Pasithea Therapeutics Corp. (KTTA) Historical Enterprise Value (quarterly & annually)

How has KTTA Enterprise Value performed in the past?

The mean historical Enterprise Value of Pasithea Therapeutics Corp. over the last ten years is 3.35M. The current -3926976.00 Enterprise Value has changed -11838.70% with respect to the historical average. Over the past ten years (40 quarters), KTTA's Enterprise Value was at its highest in in the March 2021 quarter at 928.69M. The Enterprise Value was at its lowest in in the March 2023 quarter at -19407123.50.

Pasithea Therapeutics Corp. (KTTA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pasithea Therapeutics Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pasithea Therapeutics Corp. (KTTA) Average Enterprise Value

How has KTTA Enterprise Value performed in the past?

The current Enterprise Value of Pasithea Therapeutics Corp. (KTTA) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Pasithea Therapeutics Corp. (KTTA) Enterprise Value vs. Peers

How is KTTA’s Enterprise Value compared to its peers?

Pasithea Therapeutics Corp.’s Enterprise Value is less than Nutriband Inc. (43.49M), less than ZIVO Bioscience, Inc. (40.97M), less than MediciNova, Inc. (45.42M), less than Eliem Therapeutics, Inc. (329.54M), less than Virax Biolabs Group Limited (9.05M), less than Blue Water Vaccines, Inc. (8.67M), greater than Revelation Biosciences, Inc. (-10569356.00), less than Hillstream BioPharma, Inc. (1.48M), less than Kiora Pharmaceuticals, Inc. (4.04M), less than Kezar Life Sciences, Inc. (30.94M), less than Kronos Bio, Inc. (12.94M), less than Quoin Pharmaceuticals, Ltd. (-397055.00), less than RenovoRx, Inc. (14.41M), less than ABVC BioPharma, Inc. (10.50M), less than Indaptus Therapeutics, Inc. (8.12M), less than Better Therapeutics, Inc. (7.71M), less than Forte Biosciences, Inc. (1.13M), less than PaxMedica, Inc. Common Stock (-650660.00),

Build a custom stock screener for Pasithea Therapeutics Corp. (KTTA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pasithea Therapeutics Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pasithea Therapeutics Corp. (KTTA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pasithea Therapeutics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.